{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
Why is Biofil Chemicals falling/rising?
As of 02-Dec, Biofil Chemicals & Pharmaceuticals Ltd witnessed a notable decline in its share price, falling 4.1% to ₹36.02, reflecting persistent underperformance against market benchmarks and underlying fundamental challenges despite some recent positive earnings growth.
Biofil Chemicals & Pharmaceuticals Falls to 52-Week Low of Rs.35.6
Biofil Chemicals & Pharmaceuticals touched a new 52-week low of Rs.35.6 today, marking a significant decline amid a series of consecutive trading sessions with negative returns. The stock has been under pressure, trading below all major moving averages and lagging behind its sector and benchmark indices.
Biofil Chemicals & Pharmaceuticals Falls to 52-Week Low of Rs.37.71
Biofil Chemicals & Pharmaceuticals has reached a new 52-week low of Rs.37.71, marking a significant decline in its stock price amid a period of sustained downward movement. The stock has underperformed its sector and broader market indices, reflecting ongoing challenges in its financial performance and market positioning.
Biofil Chemicals Q2 FY26: Revenue Surge Masks Profitability Collapse
Biofil Chemicals & Pharmaceuticals Ltd. reported a dramatic quarter-on-quarter revenue surge of 110.58% in Q2 FY26, with net sales reaching ₹13.54 crores compared to ₹6.43 crores in Q1 FY26. However, the seemingly positive headline numbers concealed a troubling deterioration in profitability, with net profit collapsing 96.68% to just ₹0.08 crores from ₹2.41 crores in the previous quarter. The stock, trading at ₹39.00 with a market capitalisation of ₹64.00 crores, has declined 38.56% over the past year, significantly underperforming both the Sensex and its pharmaceutical sector peers.
How has been the historical performance of Biofil Chemicals?
Biofil Chemicals has experienced fluctuating financial performance, with net sales declining from 40.04 Cr in March 2024 to 33.40 Cr in March 2025, alongside decreased profitability and negative cash flow in the latest fiscal year. Total assets and liabilities increased, indicating a challenging financial environment.
How has been the historical performance of Biofil Chemicals?
Biofil Chemicals has experienced fluctuating financial performance, with net sales decreasing to 33.40 Cr in March 2025 from 40.04 Cr in March 2024, while total assets increased to 50.96 Cr. Operating profit and profit after tax also declined, indicating mixed results overall.
Why is Biofil Chemicals falling/rising?
As of 06-Nov, Biofil Chemicals & Pharmaceuticals Ltd's stock price is Rs 38.60, down 2.53%, and has declined 5.14% over the last two days. The stock is underperforming significantly compared to the market, with a year-to-date decline of 32.28% and a notable drop in investor participation.
Biofil Chemicals Hits 52-Week Low as Stock Plummets to Rs 38
Biofil Chemicals & Pharmaceuticals has reached a 52-week low, reflecting a significant decline in its stock price. The company has underperformed its sector and consistently traded below key moving averages. Despite some positive quarterly results, long-term fundamentals indicate weak growth, posing challenges for the company.
Why is Biofil Chemicals falling/rising?
As of 03-Nov, Biofil Chemicals & Pharmaceuticals Ltd is seeing a price increase to Rs 40.69, up 3.06% over the last two days, despite a year-to-date decline of 28.61%. The stock has gained traction recently, outperforming the Sensex in the short term, but faces significant long-term challenges.
Biofil Chemicals Hits New 52-Week Low at Rs. 38 Amid Decline
Biofil Chemicals & Pharmaceuticals has reached a new 52-week low, with its stock price declining significantly. The company has underperformed its sector and experienced a notable drop over the past year. Despite some positive quarterly results, long-term fundamentals remain weak, raising concerns about its financial stability.
Biofil Chemicals & Pharmaceuticals Hits New 52-Week Low at Rs. 38
Biofil Chemicals & Pharmaceuticals has reached a new 52-week low of Rs. 38, reflecting a significant decline in its stock performance. The company has consistently underperformed against key moving averages and has experienced a substantial one-year decline, contrasting with broader market gains. Long-term fundamentals indicate weak growth and concerns over debt servicing.
Why is Biofil Chemicals falling/rising?
As of 30-Oct, Biofil Chemicals & Pharmaceuticals Ltd's stock price is Rs 38.35, down 1.69%, and has declined 3.64% over the last two days. The stock is near its 52-week low and has underperformed significantly compared to the Sensex, indicating weak investor sentiment and a challenging market environment.
Biofil Chemicals Hits New 52-Week Low at Rs. 38.01
Biofil Chemicals & Pharmaceuticals has hit a new 52-week low, with its stock price declining significantly over the past two days. The company is trading below key moving averages and has seen a substantial year-over-year decline, despite reporting strong quarterly profit growth. Concerns about its long-term fundamentals persist.
Biofil Chemicals Hits New 52-Week Low at Rs. 39 Amid Market Gains
Biofil Chemicals & Pharmaceuticals has reached a new 52-week low of Rs. 39, reflecting a significant decline in stock performance. The company has underperformed its industry, with a notable drop over the past two days. Its long-term fundamentals indicate weak growth and low return on equity.
Biofil Chemicals Hits 52-Week Low as Stock Plummets to Rs. 40.01
Biofil Chemicals & Pharmaceuticals has hit a new 52-week low, reflecting a 46% decline over the past year, contrasting with the Sensex's slight gain. The company faces challenges with low profitability and a negative growth rate in operating profits, despite reporting positive quarterly results.
Why is Biofil Chemicals falling/rising?
As of 07-Oct, Biofil Chemicals & Pharmaceuticals Ltd's stock price is Rs. 40.50, down 1.53%, and has reached a 52-week low. The stock has significantly underperformed its sector and the broader market, with a year-to-date decline of 28.95% and a notable drop in investor interest.
Biofil Chemicals & Pharmaceuticals Hits New 52-Week Low at Rs. 40.21
Biofil Chemicals & Pharmaceuticals has reached a new 52-week low, reflecting a substantial decline in its stock price over the past year. Despite recent gains, the company struggles with poor long-term fundamentals, including a negative growth rate in operating profits and low return on equity, indicating ongoing financial challenges.
Biofil Chemicals Faces Market Challenges Amid Shift to Bearish Technical Indicators
Biofil Chemicals & Pharmaceuticals has experienced a recent evaluation adjustment, reflecting changes in its market position and technical indicators. The stock's performance has been challenging, with significant declines in returns and weak long-term fundamentals, despite some positive results in the latest quarter.
How has been the historical performance of Biofil Chemicals?
Biofil Chemicals has shown mixed historical performance, with net sales and operating income peaking at 40.04 Cr in Mar'24 before declining to 33.40 Cr in Mar'25. While total assets increased, cash flow from operating activities turned negative in Mar'25, indicating overall fluctuations in financial metrics.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
